Explore the intersection of genetics and artificial intelligence in this Stanford seminar, focusing on the application of AI to ALS research and drug development. Gain insights into the speaker's journey from learning to code to pursuing an MD/PhD, and discover the challenges and opportunities in the pharmaceutical industry. Learn about innovative approaches like using human "brains in a dish" to study neurodegeneration, and understand why this field is crucial as death rates from neurodegenerative diseases continue to rise. Acquire valuable advice on building a support network and seeking guidance in this cutting-edge field of study.
Overview
Syllabus
Introduction.
Our first use case: ALS.
HOW I LEARNED TO CODE.
STARTING AN MD/PHD.
Pharma is paying for failure..
Veteran Drug Developers.
DATA ADVANTAGE.
Human "brains in a dish".
Neurodegeneration is the only disease with growing death rates.
Know where to get advice Find a support network.
Taught by
Stanford Online
Tags
Related articles
Reviews
5.0 rating, based on 2 Class Central reviews
-
Quite intriguing by viewpoint of drug therapy. This means that in future AI induced treatment options can lead a way to solve inexplicable diseases.
-
When molecular biology came into work computational biology or AI come side by side for having better research.
